Title Image

List of publications



  1. Gisela Da Silva Borges, Ravi Shrivastava, Monika Rousse (2018). The Discovery of VB-Gy Filmogen Glycerol Should Revolutionize Hemorrhoidal Treatment in the Future. Journal of Clinical Trials & Research. JCTR, 1(1): 5-7.



  1. Shrivastava L, Borges G, Shrivastava R (2018). Clinical efficacy of a dual action, topical anti-edematous and anti-inflammatory device for the treatment of external hemorrhoids. Journal of Clinical and Experimental Pharmacology (Clin Exp Pharmacol) 2018, 8:1.



  1. Shrivastava L, Schütte H, Malik P, Shrivastava R. A New Class of Polymeric Anti-Allergen Nasal Barrier Film Solution for the Treatment of Allergic Rhinitis. J Allergy Ther. 2017; 8: 263. doi:10.4172/2155-6121.1000263



  1. Shrivastava R, Carrois F, Pisak M, Chabrillat T, Shrivastava R. Clinical efficacy of novel filmogen, antimicrobial, cleaning, fluidizing cough treatment. J Clin Trials. 2017; 7:318. doi: 10.4172/2167-0870.1000318.



  1. Shrivastava RM, Tourret E, Schutte H, Shrivastava RS and Roura F. Clinical Efficacy of a New Filmogen Polymeric Glycerol Solution for the Treatment of Rhinosinusitis. J Clin Respir Dis Care. 2017; 3: 130. doi:10.4172/2472-1247.1000130.



  1. Rousse M, Schütte H, Guy M, Clairefond G, Shrivastava R, Shrivastava R. A Randomized, Double-blind, Controlled Study to Evaluate Clinical Efficacy and Safety of Novel Filmogen Osmotic Treatment for Pharyngitis. Clin. Invest. (Lond.) (2017) 7(2).


  1. Cucuat N, Adel Adly S, Rauscher D, Mukerji Joydeep, Hamelin L, Shrivastava R. A new generation of throat cleaning and healing filmogen solution for the treatment of productive (wet) cough. J Pulm Respir Med. 2017; 7:4. DOI: 10.4172/2161-105X.1000415.



  1. Georges M, Ben Miled H, Adel Adly S, Trouiller R, Shrivastava R. Clinical efficacy of a new generation of multi-target, anti-edematous, anti-inflammatory, tissue repairing topical polymeric liquid bandage for the treatment of internal hemorrhoids. J Clin Exp Dermatol Res. 2017; 8: 403. doi:10.4172/2155-9554.1000403.


  1. Shrivastava R, Rousse M, Dru L, et al. Recent Advances in the Use of Polymerics as Topical Protein Antagonists. Review article: Eur J Pharm Med Res, 2015; 2(5), 1627-1660. ISSN: 3294-3211.


  1. Shrivastava R, Cucuat N, Rousse M, et al. A New Generation of Topical Chronic Wound Treatments Containing Specific MMP Inhibitors. Chronic Wound Care Management and Research (Dove Press). 2014; 1, 31-40. ISSN: 2324-481X.


  1. Rousse M, Cucuat N, Janicot C, Shrivastava R. Innovative Scientific Concept of Topical Virus Glycoprotein Inhibitors Incorporated in Hyperosmotic Glycerol Revolutionizes Future Prospects in the Treatment of Viral and Bacterial Throat Infections. Int J Pharm Sci Drug Res. 2014; 6 (1); 1-11. ISSN: 0975-248X.


  1. Shrivastava R, Swity Deshmukh. A new therapeutic approach to treat oral mucositis using specific MMP blockers in an osmotically active solution. J Cancer Res & Treatment. 2013; 1 (1), 4-11, 2013. DOI: 10.12691/jcrt-1-1-2


  1. Shrivastava R. A new therapeutic approach to neutralize throat surface proteases and virus glycoproteins simultaneously for the treatment of influenza virus infection. International Journal of Virology, 1-11, 2011. ISSN 1816-4900 / DOI: 10.3923/ijv.2011.



  1. Shrivastava R. A pilot clinical trial to evaluate the efficacy of a topical antiviral osmotically active hypertonic solution (VB-Th4) for the treatment of influenza virus induced sore throat. J Clinic Trials (2011) 1:102. doi:10.4172/2167-0870.1000102


  1. Shrivastava R. Deshmuks S. Clinical efficacy of a specific tannin rich osmotically active solution for the treatment of labial herpes. Int J Biol & Pharma Res. 4(4), 242-249, 2013. eISSN: 0976-3651.


  1. Shrivastava R, Deshmukh S, Rousse M. Comparison of a hypertonic tannin-rich solution vs 3% NaCl solution as treatment for rhinosinusitis. J PharmTech Res. 2013; 3(2), 1-9. ISSN: 2249-3387


  1. Shrivastava R. Clinical efficacy of a topical cytokine inhibitor compared to commonly prescribed drugs for the treatment of psoriasis, eczema and dermatitis. Int J Mod Pharm Res. 2013; 2 (4); 1-15. ISSN 2319-5878.


  1. Shrivastava R, Cucuat N, Shrivastava C, Rousse M. Multiple cytokine inhibition through specific procyanidin – enriched plant extracts: Implications for the treatment of psoriasis, eczema and dermatitis. Int J Pharmacy & Plant Sci. 2013; 1 (4), 42-60. ISSN: 2320-5830.


  1. Shrivastava R. Clinical evidence to demonstrate that simultaneous growth of epithelial and fibroblast cells is essential for deep wound healing. Diabetes Research and Clinical Practice, 92-99, 2011.


  1. Shrivastava R. Associating a hypertonic solution with specific plant procyanidins for the treatment of genital herpes. J Pharma & Sci Innovation. 2013; 2 (1) 47-51.


  1. Shrivastava R, Cucuat N, John GW. Effects of Alchemilla vulgaris and Glycerine on Epithelial and Myofibroblast Cell Growth and Cutaneous Lesion Healing in Rats. Phytotherapy Research 21, 369-373, 2007.


  1. Shrivastava R, John GW. Treatment of common mouth ulcers with topical Alchemilla vulgaris in glycerine (Aphtarine®). Clin Drug Investig, 26(10): 567-573, 2006.


  1. Shrivastava R, Pechadre JC, John GW. Tanacetum parthenium and Salix alba (Mig-RL®) Combination in Migraine Prophylaxis. A prospective, open-label study. Clin Drug Invest, 26(5): 287-296, 2006.


  1. Shrivastava R, Vincent B, Gobron S, Cucuat N, John GW. Evidence for growth-promoting effects of Omega n-3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells. Nutritional Neuroscience, October/December; 8(5/6): 317-321, 2005.


  1. Shrivastava R, Durand F. The benefit/risk ratio. A handbook for the rational use of potentially hazardous drugs. Edited by Hans C. Korting and Monika Schäfer-Korting. CRC Press LLC, 1999.


  1. Shrivastava R, Durand F, Lambropoulos P. Beneficial effects of a naturally-occurring exceptionally mineral-rich water, Hydroxydase®, on cholesterol-induced atherosclerotic lesions in rabbits. New aspects of trace element research. Eds: M. Abdulla et al., 1999.


  1. Shrivastava R. In vitro Tests in Pharmacotoxicology: Can we fill gap between scientific advances and industrial needs? Fourteenth Scandinavian Cell Toxicology Congress. ALTA 25, 339-340, 1997.


  1. Seibert H, Balls M, Fentem JH, Vianchi V, Clothier RH, Dierickx PJ, Ekwall B, Garle MJ, Gomez-Lechon MJ, Gribaldo L, Gülden M, Liebsch M, Rasmussen E, Roguet R, Shrivastava R, Walum E. Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM Workshop 161,2. ATLA 24, 499-510, 1996.


  1. Shrivastava R, John GW, Chevalier A, Beaugard M, Rispat G, Slaoui M, Masingham R. Paracetamol potentiates isaxonine toxicity in vitro. Toxicology Letters 73, 167-173, 1994.


  1. Shrivastava R, Chevalier A, Slaoui M, John GW. An in vitro method using vascular smooth muscle cells to study the effect of compounds on cell proliferation and intracellular lipid accumulation. Meht Find Exp Clin Pharmacol, 15(6): 345-350, 1993.


  1. John GW, Shrivastava R, Chevalier A, Pognat JF, Massingham R. An in vitro investigation of the relationships between potency, lipophilicity, cytotoxicty and chemical class of representative calcium antagonist drugs. Pharmacological Research, Vol. 27, N°3, 1993.
  2. Rispat G, Slaoui M, Weber D, Salemink P, Berthoux C, Shrivastava R. Haematological and plasma biochemical values for healthy Yucatan micropigs. Laboratory Animals, 27, 368-373, 1993.


  1. Shrivastava R, John GW, Massingham R. Calcium antagonists can be classified using in vitro toxicity and potency indices. Journal of applied toxicology, Vol 12(5), 329-332, 1992.


  1. Shrivastava R, Delomenie C, Chevalier A, John GW, Ekwall B, Walum E, Massingham R. Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biology and Toxicology, Vol 8, N°2, 157-170, 1992.


  1. Shrivastava R, John GW, Rispat G, Chevalier A, Massingham R. Can the in vivo maximum tolerated dose be predicted using in vitro techniques? A working hypothesis. Alternatives to Laboratory Animals 19, 393-402, 1991.


  1. Shrivastava R, Ratinaud MH, Julien R. Differential toxicity of cytosine arabinoside to cell kinetics in normal sheep sinus cells and sheep tumour cell line in vitro. Toxic in Vitro, Vol 4, N°2, 143-147, 1990.


  1. Shrivastava R, Ratinaud MH, Julien R. Comparative flow cytometric analysis of bleomycin toxicity on normal and tumour sheep cell kinetics in vitro. Journal of applied toxicology, Vol 10(2), 99-103, 1990.


  1. Shrivastava R, Sowala H, Nicolas A, Julien R. Establishment, identification and characterization of a new sheep sinus tumor cell line. Biology of the Cell, 59, 169-174, 1987.


  1. Shrivastava R, Nicolas A. Lignée de cellules ayant pour origine une tumeur nasale du mouton. Ann Rech Vet, 1984, 15(1), 131-132.

40. Shrivastava R, Le Jan C. Non-specific antiviral activity of bovine leukocytes against bovine rhinotracheitis virus in vitro. Annals of INRA, 1983.